Top Stories
-
Boosting thalamic activity could help treat cognitive symptoms in schizophrenia related to altered prefrontal cortex function
Topic
-
Belinda Busogi discovered her research calling in a program that pairs Columbia psychiatry researchers with historically underrepresented racial or ethic groups.
Topic
-
Faculty from Columbia Psychiatry will be speaking on a wide range of issues at the American Psychiatric Association Annual Meeting, May 21-25, 2022.
Topic
-
New insights into genetic architecture of disease hold promise for improved risk prediction and novel drug design.
Latest News
- December 8, 2021
Columbia study finds rates are lowest among rural, Black, Hispanic, and Medicaid patients.
Topic
- November 8, 2021
New research at Columbia University Irving Medical Center shows equine therapy can jump-start the healing process for veterans who suffer from posttraumatic stress disorder (PTSD).
Topic
- November 3, 2021
As more states legalize cannabis for medical or recreational purposes its use during pregnancy is increasing, along with the potential for abuse or dependence.
Topic
- November 2, 2021
Five-year Columbia clinical trial indicates rapid cognitive shift diminishes suicidal thoughts, independently of improvement in depressive symptoms
Topic
- September 21, 2021
Columbia Psychiatry's Caroline Arout uses quantitative sensory testing, or QST, for assessing the effectiveness of cannabis for therapeutic uses.
- August 10, 2021
A collaborative study from Columbia University and the Copenhagen Research Centre for Mental Health examines the relationship between Lyme disease and psychiatric outcomes.
Topic
- July 21, 2021
A Columbia University article in JAMA Psychiatry makes the case for doing more to make mental health care non-racist and to take steps for racial equity in clinics and communities.
Topic
- May 26, 2021
Columbia study also finds people with schizophrenia, overall, have a 4.5-fold increased risk of dying from suicide.
- May 24, 2021
A Columbia study looked at a short and promising approach that could encourage more health workers to get the mental health care they need via a method centered on a three-minute video.
Topic
-
Source:
Medpage TodayFebruary 24, 2021Dr. Jeffrey Lieberman and co-authors hypothesized that combining the xanomeline with trospium could lessen xanomeline's typical side effects in treating schizophrenia.
